Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-12-017799)

Filing Details

Accession Number:: 0001127602-12-017799
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2012-05-22 17:49:53
Reporting Period:: 2012-04-27

Filing Date:: 2012-05-22
Accepted Time:: 2012-05-22 16:49:53
Original Submission Date:: 2012-04-30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1097264	Allos Therapeutics Inc	ALTH	Pharmaceutical Preparations (2834)	541655029

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1489966	Q Charles Morris	11080 Circlepoint Road Suite 200 Westminster CO 80020	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-04-27	7,970	$1.81	655,031	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

These shares are being sold pursuant to a 10b5-1 plan for Charles Q. Morris in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on April 26, 2012.